Patents Assigned to Aveta Biomics, Inc.
  • Patent number: 11701402
    Abstract: Disclosed are compositions and methods for treating or ameliorating the symptoms of cancer (e.g., oral cancer) by using a poly-pharmaceutical drug, whose composition consists of relationally optimized ratios of bioactive compounds to enhance their pharmacological characteristics.
    Type: Grant
    Filed: April 2, 2019
    Date of Patent: July 18, 2023
    Assignee: Aveta Biomics, Inc.
    Inventors: Parag G. Mehta, Sharmila Mudgal, Lal Hingorani, Luis Z. Avila
  • Publication number: 20210252097
    Abstract: Disclosed are compositions and methods for treating or ameliorating the symptoms of cancer (e.g., oral cancer) by using a poly-pharmaceutical drug, whose composition consists of relationally optimized ratios of bioactive compounds to enhance their pharmacological characteristics.
    Type: Application
    Filed: April 2, 2019
    Publication date: August 19, 2021
    Applicant: Aveta Biomics, Inc.
    Inventors: Parag G. MEHTA, Sharmila MUDGAL, Lal HINGORANI, Luis Z. AVILA